Upgrades/Downgrades
Updated: 23-Sep-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Sunrise Realty Trust | SUNS | New Street | Sell » Neutral | ||
| Magnolia Oil & Gas | MGY | Siebert Williams Shank | Hold » Buy | $30 » $32 | |
| RXO, Inc. | RXO | Susquehanna | Negative » Neutral | $19 | |
| Microsoft | MSFT | Stifel | Hold » Buy | $575 | |
| Lakefront Biotherapeutics NV | LKFT | RBC Capital Mkts | Sector Perform » Outperform | $45 | |
| Graphic Packaging | GPK | JP Morgan | Neutral » Overweight | $11.50 | |
| Editas Medicine | EDIT | Guggenheim | Neutral » Buy | $5 | |
| BP | BP | JP Morgan | Neutral » Overweight | ||
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Realty Income | O | Scotiabank | Sector Outperform » Sector Perform | $59 | |
| TotalEnergies SE | TTE | JP Morgan | Overweight » Neutral | ||
| PG&E | PCG | UBS | Buy » Neutral | $14 | |
| Dauch | DCH | Jefferies | Buy » Hold | $7.10 | |
| Compass Therapeutics | CMPX | Wedbush | Outperform » Neutral | $1 | |
| CBIZ | CBZ | William Blair | Outperform » Mkt Perform | ||
| Autoliv | ALV | Wolfe Research | Outperform » Peer Perform | ||
| Accelerant Holdings | ARX | Raymond James | Mkt Perform » Underperform | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Quoin Pharmaceuticals | QNRX | Lake Street | Buy | $20 | |
| MercadoLibre | MELI | New Street | Buy | $2450 | |
| Madrigal Pharmaceuticals | MDGL | Citigroup | Buy | $725 | |
| Maze Therapeutics | MAZE | Citigroup | Buy | $50 | |
| Viatris | VTRS | Oppenheimer | Outperform | $25 | |
| Vanda Pharma | VNDA | Oppenheimer | Outperform | $10 | |
| Toro | TTC | Oppenheimer | Outperform | $120 | |
| Teva Pharma | TEVA | Oppenheimer | Outperform | $50 | |
| Tenet Healthcare | THC | BMO Capital Markets | Market Perform | $265 | |
| TE Connectivity | TEL | Bernstein | Outperform | $243 | |
| SiTime | SITM | Seaport Research Partners | Neutral | ||
| Semtech | SMTC | Seaport Research Partners | Buy | $200 | |
| Pulse Biosciences | PLSE | BTIG Research | Buy | $70 | |
| Pacira BioSciences | PCRX | Oppenheimer | Outperform | $32 | |
| ORIC Pharmaceuticals | ORIC | BTIG Research | Buy | $26 | |
| onsemi | ON | Seaport Research Partners | Buy | $100 | |
| Marvell | MRVL | Seaport Research Partners | Buy | $270 | |
| HubSpot | HUBS | FBN Securities | Sector Perform | $230 | |
| HCA | HCA | BMO Capital Markets | Outperform | $495 | |
| Guardian Pharmacy Services | GRDN | KeyBanc Capital Markets | Overweight | $52 | |
| Enhanced Group | ENHA | Cantor Fitzgerald | Overweight | $4 | |
| CoreWeave | CRWV | UBS | Buy | $120 | |
| Cormedix | CRMD | Oppenheimer | Outperform | $15 | |
| Community Health | CYH | BMO Capital Markets | Market Perform | $3 | |
| Collegium Pharmaceutical | COLL | Oppenheimer | Outperform | $50 | |
| Beta Bionics | BBNX | Wells Fargo | Overweight | $28 | |
| Belden | BDC | Needham | Buy | $140 | |
| Ardent Health | ARDT | BMO Capital Markets | Market Perform | $11 | |
| ANI Pharma | ANIP | Oppenheimer | Perform | ||
| Amphenol | APH | Bernstein | Outperform | $99 | |
| Amneal Pharmaceuticals | AMRX | Oppenheimer | Outperform | $27 | |
| Core Scientific | CORZ | UBS | Buy | $24 | |
| Hut 8 Mining | HUT | UBS | Buy | $143 | |
| TeraWulf | WULF | UBS | Buy | $24 | |
| Cipher Mining | CIFR | UBS | Buy | $23 | |
| Applied Digital | APLD | UBS | Buy | $38 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Axsome Therapeutics | AXSM | Truist | Buy | $285 | |
| Innoviva | INVA | Oppenheimer | Outperform | $35 | |
| AEVEX Corp. | AVEX | Jefferies | Buy | $26 | |
| Wave Life Sciences | WVE | JP Morgan | Neutral | ||
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Domino's Pizza | DPZ | Guggenheim | Neutral | $440 » $325 | |
| Meta Platforms | META | KeyBanc Capital Markets | Overweight | $780 » $900 | |
| On | ONON | Needham | Buy | $37 » $40 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |